Get startedLog in
    Picture of Fresenius SE & Co. KGaA logo

    FRE — Fresenius SE & Co. KGaA News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareConservativeLarge CapNeutral
    All News

    Brief: Fresenius Buys Remaining 45% Of Mabxience For Up To Eur 750 Mln

    Picture of Fresenius SE & Co. KGaA logoFresenius SE & Co. KGaA
    01/10/2026 06:11
    BRIEF-Fresenius Buys Remaining 45% Of Mabxience For Up To Eur 750 Mln
    Oct 1 (Reuters) - FRESENIUS SE & CO. KGAA FREn.DE:
    • ACQUIRES REMAINING 45% OF MABXIENCE
    • PRICE FOR MABXIENCE OF UP TO EUR 750 MILLION
    • OWNERSHIP TO STRENGTHEN POSITION IN BIOSIMILARS MARKET SEEN ABOVE EUR 180 BILLION BY 2035
    • ACQUISITION TO BE IMMEDIATELY ACCRETIVE TO ADJUSTED EPS AFTER CLOSING
    Further company coverage: [FREn.DE]

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 587785269;))

    Recent news on Fresenius SE & Co. KGaA

    See all news